Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 March 2018 Photo Leonie Bolleurs
Second triumph for young pollution and pharmaceutical researcher
Emmie Chiyindiko, winner of Famelab.

“I am grateful to be reaping the benefits of stepping out of my comfort zone. By facing the unfamiliar, that challenge will allow me to see what great things I am capable of,” said Emmie Chiyindiko, winner of Famelab 2018.

With FameLab, the world’s leading science communication competition, participants have just three minutes to win over the judges and crowd with a scientific talk that excels in content, clarity and charisma. Contestants from around the world participate, armed only with their wits and a few props.

Emmie won the Postgraduate School’s Three-Minute-Thesis competition for master’s level in 2017.

She said: “My research is based on the synthesis and characterisation of a series of unique metal complexes.” These complexes are used both as active pharmaceutical ingredients and cosmetic additives to reduce the detrimental effects of UV radiation on the skin. They are incorporated into anti-ulcer, gastro protective drugs, anti-asthmatic, lung disease drugs, with anti-cancer and anti-diabetic agents,” she said.

With her research she can also monitor air pollution. Formaldehyde is a known toxin to human health. “Using metal complexes, I am able to monitor the production of formaldehyde and consequently come up with exposure prevention methods,” said Emmie.

She believes that it is okay to not ”fit in“. “Mannerisms such as your quirks make you different and distinctive. Live your life intentionally, imprint your personal mark on this universe and always choose faith over fear.”

News Archive

UFS academics to present papers at Conference on Calvin Research
2010-07-05

Prof. Dolf Britz, Director: Jonathan Edwards Center Africa at the UFS, will be one of three UFS keynote speakers at the 10th International Congress on Calvin Research.
Photo: Provided


Three scholars from the University of the Free State (UFS) were invited to participate as keynote speakers at the 10th International Conference on Calvin Research that will be hosted by the UFS from 22-27 August 2010. 

“Hosting this conference is seen as an exceptional achievement since the conference represents an international, high-profiled and specialised research community where invitation to present research results is based on proven academic outputs, innovation and original research,” said Prof. Dolf Britz, Director: Jonathan Edwards Center Africa at the UFS. Prof. Britz will, as keynote speaker, present a paper on Calvin's exposition of a Biblical text that played a significant role in the ‘Freedom Struggle’ in South Africa.

The programme for the Conference on Calvin Research also provides for two workshops specially designed for postgraduate students. This will be facilitated by international scholars and the focus will be on research methodology and the academic competencies to write a dissertation.

A student from the UFS, Rev. Ntabanyane Tseuao, was selected to present a short paper at the conference. He is one of three postgraduate students who are from the Theological University Apeldoorn in the Netherlands and the University of Tübingen in Germany, respectively.

Prof. Erik de Boer, an Extraordinary Professor and Research Fellow at the UFS and Mr Eric Kayayan, a Research Fellow at the UFS, will also be keynote speakers at the conference.

Two other academics from the UFS, Prof. Adriaan Neele, an Extraordinary Professor and Research Fellow and Dr Victor d’Assonville, a Research Fellow, will also present papers.

The participation of these academics in the conference is the result of an initiative that started eight years ago to cluster South African research on Classical and Reformation Theology at the University of the Free State. - Leonie Bolleurs

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept